92 related articles for article (PubMed ID: 12674040)
1. A model for management of sublingual immunotherapy.
Frati F; Sensi L; Di Rienzo V; Senna GE; Incorvaia C; Marcucci F
Eur Ann Allergy Clin Immunol; 2003 Feb; 35(2):56-60. PubMed ID: 12674040
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy.
Rossi RE; Monasterolo G; Coco G; Silvestro L; Operti D
Vaccine; 2007 Jan; 25(5):957-64. PubMed ID: 17045368
[TBL] [Abstract][Full Text] [Related]
3. The safety of sublingual immunotherapy with one or multiple pollen allergens in children.
Agostinis F; Foglia C; Landi M; Cottini M; Lombardi C; Canonica GW; Passalacqua G
Allergy; 2008 Dec; 63(12):1637-9. PubMed ID: 19032238
[TBL] [Abstract][Full Text] [Related]
4. Safety and tolerability of ultra-rush induction, less than one hour, of sublingual immunotherapy in children.
Tripodi S; Di Rienzo Businco A; Benincori N; Scala G; Pingitore G
Int Arch Allergy Immunol; 2006; 139(2):149-52. PubMed ID: 16374025
[TBL] [Abstract][Full Text] [Related]
5. Post-marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years.
Rienzo VD; Minelli M; Musarra A; Sambugaro R; Pecora S; Canonica WG; Passalacqua G
Clin Exp Allergy; 2005 May; 35(5):560-4. PubMed ID: 15898975
[TBL] [Abstract][Full Text] [Related]
6. Physical exercise does not favour adverse reactions to allergen immunotherapy by the sublingual route.
Senna GE; Bonadonna P; Crivellaro MA; Incorvaia C; Sensi L; Frati F; Marcucci F
Eur Ann Allergy Clin Immunol; 2005 Feb; 37(2):58-9. PubMed ID: 15859363
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of high-doses sublingual immunotherapy in ultra-rush scheme in children allergic to grass pollen.
Stelmach I; Kaczmarek-Woźniak J; Majak P; Olszowiec-Chlebna M; Jerzynska J
Clin Exp Allergy; 2009 Mar; 39(3):401-8. PubMed ID: 19134016
[TBL] [Abstract][Full Text] [Related]
8. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
[TBL] [Abstract][Full Text] [Related]
9. [Multicenter drug surveillance of sublingual immunotherapy in allergic patients].
Almagro E; Asensio O; Bartolomé JM; Bosque M; de la Hoz B; Dolz I; Elorza J; Ferreiro M; García JM; Losada E
Allergol Immunopathol (Madr); 1995; 23(4):153-9. PubMed ID: 8553989
[TBL] [Abstract][Full Text] [Related]
10. Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC.
Savolainen J; Jacobsen L; Valovirta E
Allergy; 2006 Oct; 61(10):1184-90. PubMed ID: 16942566
[TBL] [Abstract][Full Text] [Related]
11. Dose dependence of immunological response to sublingual immunotherapy.
Marcucci F; Sensi L; Di Cara G; Incorvaia C; Frati F
Allergy; 2005 Jul; 60(7):952-6. PubMed ID: 15932387
[TBL] [Abstract][Full Text] [Related]
12. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually.
Panzner P; Petrás M; Sýkora T; Lesná I
Respir Med; 2008 Sep; 102(9):1296-304. PubMed ID: 18585908
[TBL] [Abstract][Full Text] [Related]
13. Randomized controlled trial of high-dose sublingual immunotherapy to treat seasonal allergic rhinitis.
Smith H; White P; Annila I; Poole J; Andre C; Frew A
J Allergy Clin Immunol; 2004 Oct; 114(4):831-7. PubMed ID: 15480323
[TBL] [Abstract][Full Text] [Related]
14. Development of an allergen extract for sublingual immunotherapy--evaluation of Staloral.
Frati F; Scurati S; Puccinelli P; Justicia JL; Adamec T; Sieber HJ; Ras L; David M; Marcucci F; Incorvaia C
Expert Opin Biol Ther; 2009 Sep; 9(9):1207-15. PubMed ID: 19601728
[TBL] [Abstract][Full Text] [Related]
15. Quantitative assessment of the compliance with once-daily sublingual immunotherapy in children (EASY project: evaluation of a novel SLIT formulation during a year).
Passalacqua G; Musarra A; Pecora S; Amoroso S; Antonicelli L; Cadario G; Di Gioacchino M; Lombardi C; Ridolo E; Sacerdoti G; Schiavino D; Senna G
Pediatr Allergy Immunol; 2007 Feb; 18(1):58-62. PubMed ID: 17295800
[TBL] [Abstract][Full Text] [Related]
16. Cost effectiveness of sublingual immunotherapy in children with allergic rhinitis and asthma.
Berto P; Bassi M; Incorvaia C; Frati F; Puccinelli P; Giaquinto C; Cantarutti L; Ortolani C
Eur Ann Allergy Clin Immunol; 2005 Oct; 37(8):303-8. PubMed ID: 17066648
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children.
Valovirta E; Jacobsen L; Ljørring C; Koivikko A; Savolainen J
Allergy; 2006 Oct; 61(10):1177-83. PubMed ID: 16942565
[TBL] [Abstract][Full Text] [Related]
18. Comparison of efficacy, safety and immunologic effects of subcutaneous and sublingual immunotherapy in birch pollinosis: a randomized study.
Mauro M; Russello M; Incorvaia C; Gazzola GB; Di Cara G; Frati F
Eur Ann Allergy Clin Immunol; 2007 Apr; 39(4):119-22. PubMed ID: 17523385
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study.
Bufe A; Ziegler-Kirbach E; Stoeckmann E; Heidemann P; Gehlhar K; Holland-Letz T; Braun W
Allergy; 2004 May; 59(5):498-504. PubMed ID: 15080830
[TBL] [Abstract][Full Text] [Related]
20. Sublingual immunotherapy: the optimism and the issues.
Pajno GB
J Allergy Clin Immunol; 2007 Apr; 119(4):796-801. PubMed ID: 17306355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
